| Identification | Back Directory | [Name]
2',3',5'-Tri-O-benzoyl-2'--C-methyl-6-azauridine | [CAS]
622379-83-3 | [Synonyms]
2',3',5'-Tri-O-benzoyl-2'--C-methyl-6-azauridine
2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-6-azauridine
2',3',5'-Tri-O-benzoyl-2'-b-C-methyl-6-azauridine
2',3',5'-Tri-O-benzoyl-2'-beta-C-methyl-6-azauridine
1,2,4-Triazine-3,5(2H,4H)-dione, 2-(2,3,5-tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-
(2R,3R,4R,5R)-5-((benzoyloxy)methyl)-2-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate | [Molecular Formula]
C30H25N3O9 | [MOL File]
622379-83-3.mol | [Molecular Weight]
571.54 |
| Hazard Information | Back Directory | [Uses]
2',3',5'-Tri-O-benzoyl-2'-beta-C-methyl-6-azauridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
T&W GROUP
|
| Tel: |
021-61551611 13296011611 |
| Website: |
www.trustwe.com/ |
|